Latest information on COVID-19

Children's hospital receives $25 million from Hewlett-Packard

- By Jonathan Rabinovitz

The Hewlett-Packard Co. announced May 2 that it has made a commitment of $25 million over 10 years to support the projected expansion of Lucile Packard Children’s Hospital and a research initiative designed to enhance the safety and quality of care for critically ill patients and their families.

HP’s new investment will help Packard Children’s to add 100 beds to its Palo Alto campus and increase access to state-of-the-art treatments for local children and expectant mothers.

“HP’s generous commitment will bring tremendous resources to bear on the future of children’s health care,” said Christopher Dawes, president and chief executive officer, Packard Children’s. “Our partnership with HP has already succeeded in translating research discoveries into more effective clinical care, and we are thrilled to have their investment as we build new facilities to provide for future generations of children and expectant mothers.”

The grant also will help sustain and advance innovative, interdisciplinary research collaborations between scientists at HP Labs — the company’s central research arm — and Packard Children’s. Using powerful bioinformatics tools, the project team will investigate issues of quality, patient safety and personalized care to achieve even better health outcomes for pediatric medicine worldwide.

“At HP, strengthening our local communities is a foundational responsibility and core to commitment to global citizenship,” said Léo Apotheker, HP president and chief executive officer. “We are working with Lucile Packard Children’s Hospital to evolve patient care through innovation and help ensure that children and families continue to receive the most advanced and innovative care.”

Since 2007, leaders in quality, safety and bioinformatics from Packard Children’s, HP Labs and HP’s Enterprise Business have worked to develop faster, safer and more personalized patient care. Leveraging an earlier investment from HP and a new computerized physician order entry system, researchers at Packard Children’s developed a system of novel prompts for the deployment of “rapid response teams” at the first inkling of trouble in hospitalized children. The effective use of these teams was found to significantly reduce mortality rates in a pediatric setting.

Previous investments from HP also enabled Packard Children’s Hospital investigators to study environmental factors in disease development, personalized cancer therapy and genome sequencing.

Researchers at Packard Children’s and HP Labs are now leveraging safety lessons from high-reliability industries such as air travel and applying them to health care, enhancing “situational awareness” to further improve patient safety and quality of care. Upcoming studies will harness methods in data-driven science to find trends and patterns in clinical, genetic and environmental data that are expected to reach new levels of personalized medicine.

Stanford Medicine integrates research, medical education and health care at its three institutions - Stanford School of Medicine, Stanford Health Care, and Stanford Children's Health. For more information, please visit the Office of Communications website at

2022 ISSUE 1

Understanding the world within us

COVID-19 Updates

Stanford Medicine is closely monitoring the outbreak of novel coronavirus (COVID-19). A dedicated page provides the latest information and developments related to the pandemic.